LPA and acute coronary syndrome: In one study performed in 76 patients with acute coronary syndrome (ACS) who underwent intravascular ultrasound(IVUS) at baseline and at 10‐month follow‐up after percutaneous coronary intervention, the results showed that patients with serum levels of Lp(a) >20 mg/dl had slight plaque progression despite of statin therapy, suggesting Lp(a) levels could be an alternative predictor of further plaque progression.10